Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Large Cell 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Multiple Myeloma 1Lung Neoplasms 1Ewing's Sarcoma Family of Tumors 1Colorectal Neoplasms 1Carcinoma, Adenosquamous 1Carcinoma 1Advanced Non-Hematologic Malignancies 1Advanced Cancer 1

Interventions

figitumumab 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Non-Hematologic Malignancies × figitumumab × Clear all
NCT01653158 2013-10-30

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Pfizer

Phase 1 Completed
46 enrolled 34 charts

Advanced Non-Hematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡